ECONOMIST Frederic Bizard has warned of the high profits being generated by Pfizer, Moderna and BioNTech as share prices moved over reactions to the new Omicron variant.
Daily Express :: City and Business Feed
ECONOMIST Frederic Bizard has warned of the high profits being generated by Pfizer, Moderna and BioNTech as share prices moved over reactions to the new Omicron variant.
Daily Express :: City and Business Feed